MED22 antibody (N-Term)
Quick Overview for MED22 antibody (N-Term) (ABIN953371)
Target
See all MED22 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 7-36, N-Term
-
Specificity
- This antibody recognizes Human MED22 / SURF5 (N-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 7-36 amino acids from the N-terminal region of Human MED22 / SURF5
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- MED22 (Mediator Complex Subunit 22 (MED22))
-
Alternative Name
- MED22 / SURF5
-
Background
- This gene is located in the surfeit gene cluster, a group of very tightly linked housekeeping genes that do not share sequence similarity. The gene is oriented in a head-to-head fashion with RPL7A (SURF3) and the two genes share a bidirectional promoter. The encoded proteins are localized to the cytoplasm. Two alternative transcript variants encoding different isoforms have been identified for this gene.Synonyms: Mediator complex subunit 22, Mediator of RNA polymerase II transcription subunit 22, Surf-5, Surfeit locus protein 5
-
Molecular Weight
- 22221 Da
-
Gene ID
- 6837
-
NCBI Accession
- NP_598395
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Target
-